spacer
home > pmps > winter 2018 > patience with patients
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Patience with Patients

What is patient adherence?

As defined by the WHO, patient adherence is the extent to which a person’s behaviour – for example, taking medication, following a diet or executing lifestyle changes – corresponds with the agreed recommendations from a healthcare provider. A low level of adherence means that the likelihood of patients taking their prescribed medication correctly is small, which can be very dangerous, in some cases.

Would you say that this is a growing or lessening concern for the pharmaceutical industry and why?

Patient adherence is currently one of the biggest challenges that the pharma industry is facing and remains a growing concern. Not only do low patient adherence levels affect healthcare efficacy, it is also extremely costly to the industry. Research shows that patients not taking their medication in line with recommendations costs the NHS £500 million per year, which, in context, is equivalent to 30,000 kidney transplants or an extra 21,000 qualified nurses.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rupert Taylor joined Essentra in 2014 as Global Category Manager Household for food and drink. He is now Global Category Manager for healthcare and personal care. Rupert’s role is to identify customer and consumer needs in the market place and deliver those solutions through the company’s portfolio of packaging, components, special technologies, security, and authentication. Prior to joining Essentra, he worked as Marketing and Innovation Director for Puratos, Brazil. Rupert’s experience spans over 20 years in delivering results in both B2B and B2C environments on a global basis.
spacer
Rupert Taylor
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2018 Call for Entries – Deadline 31st July

The PPMA Group Industry Awards, which recognise manufacturing excellence, technical innovation, entrepreneurship as well as outstanding achievement and contribution to the industry, will this year take place at a new venue – the Hilton Birmingham Metropole Hotel at the NEC - on the 25th September 2018.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement